The objective of this study was to determine the effects of level of feeding on growth, feed efficiency (gain:feed; G:F), body composition (BC), and serum concentrations of somatotropin (ST), IGF-I, and IGF-binding proteins (BP) in growing beef cattle supplemented with bovine (b) ST. In each of two consecutive years, 40 growing beef cattle were blocked by weight (average BW: yr 1 = 316 kg, yr 2 = 305 kg) and used in a 2 × 2 factorial arrangement with main effects of bST (0 or 33 g ؒ kg BW
Introduction
Administration of bovine somatotropin (bST) stimulates BW gain in cattle compared with untreated animals (Eisemann et al., 1989; Moseley et al., 1992; Preston et al., 1995) . The magnitude of response to bST in 94 AL cattle than in AL cattle (13.0 vs 8.6 ng/mL; P < 0.05) and in bST-treated cattle than in uninjected cattle (16.3 vs 5.2 ng/mL; P < 0.05). Due to a bST × level of feeding interaction (P < 0.01), the magnitude of the increase in serum ST to exogenous bST was greater (P < 0.01) in 0.75 AL cattle than in AL cattle. Relative to uninjected cattle, treatment with bST increased (P < 0.05) serum concentrations of IGF-I and IGFBP-3 and reduced (P < 0.05) concentrations of IGFBP-2. Similarly, AL cattle had greater (P < 0.05) serum concentrations of IGF-I and IGFBP-3 and reduced (P < 0.05) IGFBP-2 compared with 0.75 AL cattle. In summary, treatment with bST increased growth rate and G:F and stimulated serum IGF-I and IGFBP-3 while reducing IGFBP-2. Feeding at 0.75 ad libitum intake reduced the magnitude of response for each of these variables. Thus, limit-feeding may reduce the effect of exogenous bST on growth rate by blunting bST-induced increases in IGF-I and IGFBP-3 and bST-induced decreases in IGFBP-2. cattle is variable. For example, bST increased growth rate approximately 14% in beef cattle fed for ad libitum intake (Tripp et al., 1998) , and bST treatment combined with abomasal infusion of casein increased growth rate and N retention 45% in steers (Houseknecht et al., 1992) . However, bST did not improve growth rate in cattle that were undernourished prior to the onset of treatment (Peters, 1986) . Thus, plane of nutrition contributes to the variation in response to administration of bST in cattle.
Insulin-like growth factor-I and IGF-binding proteins (BP) have been implicated in the control of growth in cattle. Thus, the magnitude of bST-induced changes in IGF-I and IGFBP can also contribute to the variation in response to exogenous bST. Following administration of bST, concentrations of IGF-I are increased and concentrations of IGFBP are altered (Vicini et al., 1991; McGuire et al., 1992) . In addition, level of nutrient intake influences concentrations of ST, IGF-I, and IGFBP, as well as the magnitude of bST-induced IGF-I (Dawson et al., 1992; McGuire et al., 1992; Thissen et al., 1994) . Although the response of growth rate and IGF-I to level of feeding and long-term (>12 wk) administration of bST has been studied in cattle, the effect of these treatments on changes in IGFBP in cattle has not been thoroughly investigated, especially in animals fed a highforage (>95%) diet. Therefore, one of our objectives was to determine the influence of long-term administration of exogenous bST on concentrations of IGFBP, IGF-I, and ST in cattle fed a 95% forage diet for ad libitum intake or 0.75 ad libitum intake. In addition, the effects of level of feeding on bST-induced changes in growth, gain:feed (G:F), and body composition (BC) were also determined.
Materials and Methods

General
In each of two consecutive years, 40 beef cattle were used in this experiment (80 animals total). Within each year, the 40 animals were blocked by BW into two groups of 20 (one lighter block and one heavier block). Within block, animals were randomly sorted into four pens (five animals/pen, eight pens total). Pens were randomly assigned to a 2 × 2 factorial arrangement of treatments (two pens/treatment combination), with main effects of bST (0 or 33 g ؒ kg BW
) and level of feed intake (ad libitum [AL] or 0.75 AL). Thus, the experimental design was replicated in each of the 2 yr with 40 different animals each year. In yr 1, 8 steers and 32 heifers (24 Herefords and 16 Angus, average BW = 316 kg [range 242 to 383 kg], 8 to 10 mo of age) were used. In yr 2, 15 steers and 25 heifers (26 Herefords and 14 Angus, average BW = 305 kg [range 233 to 426 kg], 7 to 11 mo of age) were used. Each block/treatment combination (five animals in each combination) was balanced for sex (yr 1, one steer and four heifers; yr 2, seven block/treatment combinations had two steers and three heifers and one block/treatment combination had one steer and four heifers) and breed (yr 1, three Herefords and two Angus; yr 2, six block/treatment combination had three Herefords and two Angus and two block/ treatment combinations had four Herefords and one Angus).
Animals had a 2-wk adjustment period for adaptation to the diet, and treatments lasted for 14 wk, from December to March in both years. To avoid the confounding influence of numbers of animals within a pen on feed intake and seasonal effects on BW and BC (Petitclerc and Zinn, 1991) , treatments were administered for a constant number of days. We, and others, have successfully used this experimental design to determine treatment effects on growth, BC, and changes in serum concentrations of hormones (Tripp et al., 1998; Klemesrud et al., 2000; Rumsey et al., 2000) .
Animals were housed, unrestrained, in covered pens (225 m 2 ) with constant access to an exercise yard (525 m 2 ). Animals were fed outside in covered bunks. All groups received the same base total mixed diet, consisting of a mix of corn silage and a 52% protein supplement (95.5% forage to 4.5% supplement; 2.50 Mcal ME and 100 g protein/kg DM). Previously, we have used a similar diet and reported bST-induced changes in growth rate (Tripp et al., 1998) . This diet was formulated for animals given ad libitum access to feed to gain approximately 1.2 kg/d (NRC, 1984) . Fresh feed was weighed and offered daily at 0900 and orts were recorded the following morning. Dry matter of the diet was analyzed daily using a Koster hay and silage moisture tester (Koster, Strongsville, OH). Within block, average daily feed intake of AL animals from the previous week was used to determine the amount fed to the 0.75 AL animals. The amount of feed offered to the 0.75 AL animals during wk 1 was based on consumption during wk 2 of adaptation to the diet (21.9 and 30.2 kg DM for the lighter and heavier blocks, respectively). Water was provided for ad libitum consumption.
Animals were weighed every other week on three consecutive days, and dosages of bST (Protiva, Monsanto, St. Louis, MO) were adjusted every 2 wk based on the updated BW. Animals receiving bST were given daily injections of 33 g bST/kg BW subcutaneously in the region of the tailhead. Injections were given at approximately 1000 each day in a holding chute. All control animals were also walked through this chute at approximately 1000 with no injections given.
Blood was collected by jugular venipuncture during both years to determine concentrations of serum ST, IGF-I, IGFBP-2, and IGFBP-3. Blood samples were collected at wk 0, 6, and 14 of the experiment. Five samples (10 mL), each 30 min apart, were collected from each animal during each sampling session. On each day of sampling, the first sample was collected immediately after the daily bST injection was administered. In addition, on d 42 of yr 2, one pen of five animals from each treatment combination (20 animals total; all from the heavier block) were sampled hourly for 53 h to determine bST profiles across two injection intervals. This sampling began at 0800, with the final sample taken 52 h later. Samples were stored overnight at 4°C. Sera were obtained the following day by centrifugation at 1,800 × g for 30 min and stored at −20°C until they were assayed. Serum ST was quantified in all samples using procedures of Kazmer et al. (1992) . Concentrations of IGF-I were determined using the fifth sample taken from each animal at each sampling session according to Johnson et al. (1996) . Serum IGFBP-2 and IGFBP-3 were determined using the fourth sample taken at each sampling session according to Freake et al. (2001) . Following determination of serum ST, samples from yr 1 were lost and therefore were not analyzed for IGF-I and IGFBP.
At wk 0, 6, and 14, backfat thickness and longissimus muscle areas (LEA) were measured by ultrasonography in all animals as previously described (Tripp et al., 1998) .
Statistical Analysis
The influence of bST and level of feeding on cattle growth and feed consumption were analyzed as a 2 × 2 factorial arrangement in a complete block design. Replicate was included in the model to account for variation between yr 1 and yr 2 of the experiment. Body weight, ADG, feed consumption, backfat thickness, LEA, and serum ST (periodic and extended sampling periods), IGF-I, and IGFBP-2 and -3 data were included in these analyses as repeated measures in a subplot, using a model that accounted for repeated samples from the same experimental unit (Gill, 1986) . Appropriate error terms were used to test main (animal within bST and feed by replicate) and subplot (animal within bST and feed by time by replicate) effects. Feed consumption was calculated based on DM consumed per pen. Differences between treatment means were evaluated using GLM procedure in SAS (SAS Inst. Inc., Cary, NC).
There was an effect of year (P < 0.01) on all variables quantified in this study. However, with the exception of serum concentrations of ST, there were no interactions (P > 0.10) between year of experiment and main effects of bST or level of feeding. Although the magnitude of effect of treatments was different between yr 1 and yr 2, the direction of change was consistent between the 2 yr. Given that the direction of change of the main effects was similar and there was no interaction between year and main effects, the data are reported as means across the 2 yr.
Results
At the beginning of treatment, animals averaged 310.6 ± 5.2 kg BW, which increased to 428.3 ± 6.6 kg at the end of the experiment, resulting in an ADG across treatments of 1.20 ± 0.07 kg (Figure 1 ). Body weight gains in AL cattle were 40.5% greater (P < 0.01) than those in 0.75 AL animals (137.5 ± 2 kg vs 97.9 ± 2 kg, respectively). Relative to 0.75 AL animals, AL cattle had greater (P < 0.01) ADG (1.00 ± 0.07 vs 1.39 ± 0.07 kg/ d, respectively). Over the entire experiment, treatment with bST increased (P < 0.01) total BW gain and ADG (122.7 ± 2 kg and 1.25 ± 0.07 kg/d, respectively) compared with those of uninjected cattle (112.7 ± 2 kg and 1.14 ± 0.07 kg/d, respectively; Figure 1 ) such that bSTtreated cattle gained 8.9% more BW than the untreated animals. There was a tendency (P = 0.10) for a bST × level of feeding interaction such that bST improved growth rate in AL and 0.75 AL animals, but the magnitude of response to bST was larger in AL cattle than in cattle fed 0.75 AL (10.6 vs 7.8%, respectively; Figure  1 ). In addition, over time, there was a block × bST interaction (P < 0.05) such that bST-induced BW gain was greater in the heavier block of cattle than in the lighter block of animals (13.5 vs 4.3%, respectively; individual block × treatment data not shown).
Feed consumption (dry matter intake/pen) for all cattle averaged 29.1 ± 2.1 kg/d at the beginning of the ) and level of feed intake (ad libitum [AL] or 0.75 AL). Treatment with bST and AL feed intake increased (P < 0.01) BW gains. There was a tendency (P = 0.10) for a bST × level of feeding interaction, such that the magnitude of response to bST was greater in AL cattle than in cattle fed 0.75 AL. Pooled SEM of BW = 2.0, n = 80. experiment and increased (P < 0.01) to 42.1 ± 2.1 kg/d at the end of the experiment. There was no effect (P > 0.10) of bST on feed intake. However, over the course of the experiment, bST improved G:F 8.1% (13.3 vs 12.3 g:kg, P < 0.05) compared with no bST injection. Gain:feed tended to be increased 5.6% (13.2 vs 12.5 g:kg, P = 0.10) by AL feed intake compared with 0.75 AL feed intake.
Averaged across all animals, backfat depth increased (P < 0.01) from 1.1 ± 0.02 cm at the start of the experiment to 1.3 ± 0.02 cm at the end of the experiment. Across all animals, LEA averaged 32.5 ± 1.8 cm 2 at the beginning of treatments and increased (P < 0.01) to 41.05 ± 2.1 cm 2 at the end of the experimental period. Treatment with bST did not (P > 0.10) influence backfat depth or LEA. At the conclusion of the experiment, backfat depth (1.20 ± 0.02 vs 1.42 ± 0.02 cm), and LEA (39.5 ± 2.1 vs 42.6 ± 2.1 cm 2 ) were less (P < 0.05) in 0.75 AL cattle than in AL animals, respectively (individual treatment data not shown).
Serum ST concentrations are shown in Table 1 . Due to greater (P < 0.05) concentrations of ST in one group of cattle (AL, 0 bST; yr 2) relative to the other groups at wk 0, there was a year of experiment × bST interaction (P < 0.05). Therefore, the data from each year of the experiment were not combined. Compared with uninjected cattle, cattle treated with bST had increased (P < 0.05) serum concentrations of ST in both years. In addition, there was an interaction between bST treatment and level of feeding such that in bST-treated animals serum concentrations of ST were greater (P < 0.05) in 0.75 AL cattle than in AL animals, but concentrations of ST were not different (P > 0.10) between the AL and Samples collected for bST analysis were collected every 0.5 h for 2.5 h. Pooled SEM = 0.83.
Within year, least squares means within column are different if superscripts differ (P < 0.05).
e,f,g
Within year, least squares means within row are different if superscripts differ (P < 0.05).
0.75 AL groups not treated with bST (Table 1) . Over the extended blood sampling period, serum ST profiles increased (P < 0.01) sharply within 1 to 2 h of injection of bST, peaked 6 h following injection, and gradually returned to preinjection concentrations over the next 18 h (Figure 2 ). Serum concentrations of IGF-I, IGFBP-2, and IGFBP-3 are shown in Table 2 . Blood samples collected from cattle in yr 1 were unavailable for determination of serum concentrations of IGF-I, IGFBP-2, and IGFBP-3, and therefore data for these variables are from yr 2 only. Across all samples, bST increased (P < 0.01) concentrations of IGF-I relative to those in uninjected animals (347.7 vs 193.7 ng/mL, respectively). The increase in serum IGF-I from wk 0 to 14 was greater (P < 0.01) in animals treated with bST than in uninjected cattle (178 vs 30%, respectively). Concentrations of IGF-I were reduced (P < 0.05) in 0.75 AL animals rela- ؒd −1 ). Injections of bST (denoted by arrows) were administered to the bST groups at 3, 27, and 51 h. Overall, injection of bST increased (P < 0.01) serum concentrations of ST. Pooled SEM = 2.73, n = 20.
tive to AL animals (249.4 vs 292.0 ng/mL, respectively), and this difference (P < 0.01) was apparent at the start of bST treatment (wk 0; Table 2 ). For IGF-I, there was no interaction (P > 0.10) between bST treatment and level of feeding. Concentrations of IGFBP-2 declined (P < 0.05) during the course of the experiment. The decline from the beginning of the experiment to the end was greater (P < 0.05) in cattle treated with bST than in uninjected animals (48.0 vs 33.1%, respectively). Similarly, the decline in IGFBP-2 in AL cattle was greater (P < 0.05) than that in 0.75 AL animals (44.4 vs 36.5%, respectively). Averaged across all samples, concentrations of IGFBP-3 were increased 38.5% (P < 0.01) in bST-treated cattle compared with uninjected animals. After 14 wk of treatment, concentrations of IGFBP-3 were 54.3% greater (P < 0.01) in bST-treated cattle than in uninjected animals ( Table 2) . Across all samples, serum concentrations of IGFBP-3 were 13.1% greater (P < 0.01) in AL than in 0.75 AL animals ( Table 2) . A difference (P < 0.05) in IGFBP-3 due to diet was apparent after the 2-wk adjustment period to diet at the start of bST treatment (wk 0, Table 2 ). There was no interaction (P > 0.10) between bST treatment and level of feeding for IGFBP-2 and -3.
Discussion
The increased BW in cattle treated with bST in the current experiment is consistent with previous reports (Enright et al., 1990; Preston et al., 1995; Holzer et al., 1999 ). In the current experiment, the magnitude of response to bST was greater in AL cattle than in 0.75 AL cattle. Similarly, Radcliffe et al. (1997) reported 60% greater gains in dairy cattle treated with bST and fed a diet with added protein and energy relative to controls.
In the present experiment, the magnitude of bSTinduced BW gain was greater in the heavier (and older) block of animals than in the lighter (and younger) block. In agreement, McShane et al. (1989) reported that bST supplementation resulted in increased gain in heavier cattle (12 to 15 mo) but did not affect BW gain in lighter Data are the least squares means of a single sample taken 2 and 2.5 h following an injection of bST from yr 2 for IGFBP-2 and -3 and IGF-I, respectively. Within an item, least squares means within a column are different if superscripts differ (P < 0.05).
Within an item, least squares means within a row are different if superscripts differ (P < 0.01). cattle (7 to 11 mo). In contrast, others have reported significant increases in bST-induced weight gain in cattle lighter and younger than those used in the present study (Rumsey et al., 1996; Radcliffe et al., 1997) . However, in both of those reports, the diet contained more protein and energy relative to requirements than did diets in the current experiment. Indeed, Holzer et al. (2000) reported that bST did not influence growth rate of Holstein bull calves fed a limited-energy diet until the cattle reached approximately 350 kg (300 d of age). Therefore, bST may only be effective when optimal nutrition is available, especially in younger animals, and thus formulation of diets relative to the physiological state of the animal is essential to maximize the bSTinduced increase in growth rate.
Similar to previous reports (Enright et al., 1990; Schwarz et al., 1993; Holzer et al., 1999) , G:F was improved in bST-treated animals in the current study. In contrast to the current experiment, animals fed a restricted diet typically have greater G:F than animals given ad libitum access to feed , due to greater efficiency in digestibility .
Several groups (Schwarz et al., 1993; Rumsey et al., 1996; Holzer et al., 1999) have reported a reduction in carcass fat with bST treatment, indicating that treatment with exogenous bST improves the yield grade of the carcass by reducing fat accretion. In contrast, in the current experiment and those of Early et al. (1990) and Tripp et al. (1998) , backfat thickness was unchanged with bST administration. In those reports and the current experiment, ultrasonic imaging, which is more variable than direct carcass measurements (Hamlin et al., 1995) , was used to determine backfat thickness. In agreement with Moseley et al. (1992) and Dalke et al. (1992) , no difference was detected in LEA due to bST treatment in the current experiment. As expected, fat thickness was greater in animals with ad libitum intake (Zinn et al., 1989; Radcliffe et al., 1997) .
Exogenous bST increases blood concentrations of ST in cattle 4-to 15-fold (Early et al., 1990; McGuire et al., 1995; Tripp et al., 1998) . In agreement, ST concentrations in bST-treated animals were increased in the current experiment compared with those of uninjected cattle. Restricted feeding can increase blood concentrations of ST (Breier et al., 1986; Dawson et al., 1992 ). In the current experiment and that of McGuire et al. (1995) , serum ST response to bST injection was greater in cattle fed a restricted diet than in animals with ad libitum intake. As Breier et al. (1986) suggested, this may be a result of a reduction in metabolic clearance rate of ST from the blood in restricted-fed cattle. In agreement with the current experiments, Crooker et al. (1990) and Houseknecht et al. (1992) reported that serum ST profiles peaked 1 to 6 h after bST injection and declined to control values before the next injection in animals injected daily. We have previously reported that concentrations of ST in bST-supplemented cattle were increased throughout the injection cycle, compared with those in unsupplemented cattle (Tripp et al., 1998) . This difference among reports may relate to the length of time on treatment at the point of sampling. For example, Tripp et al. (1998) determined profiles after 57 d on treatment, whereas profiles were determined at 14, 23, and 42 d of bST treatment by Crooker et al. (1990) , Houseknecht et al. (1992) and in yr 2 of the current study, respectively.
Administration of bST consistently increases serum IGF-I concentration in growing cattle (Elsasser et al., 1989; Tripp et al., 1998 ). In the current study, concentrations of serum IGF-I were increased in bST-supplemented animals compared with unsupplemented animals. Similar to the results of Breier et al. (1986 Breier et al. ( , 1988 and McGuire et al. (1995) , serum concentrations of IGF-I in 0.75 AL cattle were less than those in AL cattle. In addition, the IGF-I response to exogenous bST in 0.75 AL cattle tended to be blunted compared with that in AL animals, indicating a partial separation of the ST-IGF-I axis in 0.75 AL cattle. The reduced growth response in 0.75 AL cattle may be due, in part, to this reduced response of IGF-I. For example, in mice elevated concentrations of ST without concomitant changes in IGF-I prevented increased growth rate in animals treated with exogenous ST (Liu and LeRoith, 1999) .
In agreement with previous reports (Vicini et al., 1991; Cohick et al., 1992; McGuire et al., 1995) , serum concentrations of IGFBP-3 increased in cattle treated with bST. In addition, compared with AL cattle, concentrations of IGFBP-3 were reduced in 0.75 AL animals. Thus, changes in concentrations of IGFBP-3 paralleled changes in serum concentrations of IGF-I, which is consistent with its role as the primary blood carrier of IGF-I (Jones and Clemmons, 1995) . In agreement with previous results in cattle (Vestergaard et al., 1995) , sheep (Gatford et al., 1996) , and pigs (Owens et al., 1999) , in the present experiment greater serum concentrations of IGFBP-3 were associated with faster growing animals. As reported for growth hormone-deficient children (Mandel et al., 1997) , it may be the combined increase of IGF-I and IGFBP-3 that is a determining factor in the magnitude of bST-induced growth response in cattle.
The decrease in serum concentrations of IGFBP-2 with bST treatment in the present experiment is consistent with previous reports (Vicini et al., 1991; Cohick et al., 1992) . In contrast to IGF-I and IGFBP-3, increased concentrations of IGFBP-2 are associated with reduced growth rates in mice, potentially via IGFBP-2 inhibition of IGF-I biological activity (Hoeflich et al., 1999) . Increased growth rates in bST-treated and AL cattle were associated with reduced serum concentrations of IGFBP-2. Potentially, reducing the serum concentration of IGFBP-2 with bST and(or) level of feeding enhances the biological activity of IGF-I, which results in increased growth rate.
Overall, exogenous bST stimulates growth rate and feed efficiency in beef cattle. Adequate nutrition is required to gain full advantage of exogenous bST, especially in younger and faster growing animals. Limitfeeding may reduce the effect of exogenous bST on growth rate by blunting the bST-induced increase in IGF-I and the bST-induced decrease in IGFBP-2. The potential negative impact of IGFBP-2 on growth rate in cattle requires additional study.
Implications
Growing cattle eating a high-forage diet and supplemented with bovine somatotropin (bST) can grow more rapidly and more efficiently than unsupplemented cattle. To gain full advantage of exogenous bST, it is important that cattle be fed optimal quantities of feed. The economic feasibility and(or) practicality of daily bST injection in growing beef cattle has not been addressed in this experiment, so before bST is widely adopted as a growth promotant for beef cattle these issues need to be resolved.
